Grand Theravac Life Sciences (Nanjing) Co., Ltd.

5 clinical trials · Sponsor

Record	Firm	Date
Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of TVAX-028 in the Treatment of Chronic Hepatitis B (NCT07673068)	Grand Theravac Life Sciences (Nanjing) Co., Ltd.	2026-05-31
Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in the Treatment of Chronic Hepatitis B (NCT07282249)	Grand Theravac Life Sciences (Nanjing) Co., Ltd.	2025-12-31
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Chronic Hepatitis B Patients (NCT07179653)	Grand Theravac Life Sciences (Nanjing) Co., Ltd.	2025-01-22
Study to Evaluate Immunogenicity and Safety of TVAX-008 Injection in Non/Treated Chronic Hepatitis B Patients With HBsAg≤20IU/ml or HBsAg Negative Without Serological Conversion (NCT07204236)	Grand Theravac Life Sciences (Nanjing) Co., Ltd.	2024-01-18
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Treated Patients With Chronic Hepatitis B (NCT07190742)	Grand Theravac Life Sciences (Nanjing) Co., Ltd.	2023-06-01

Every clearance here is in the API, with alerts when new ones post.